MXPA03004288A - Tratamiento de disfuncion sexual inducida por farmaco antidepresivo con apomorfina. - Google Patents

Tratamiento de disfuncion sexual inducida por farmaco antidepresivo con apomorfina.

Info

Publication number
MXPA03004288A
MXPA03004288A MXPA03004288A MXPA03004288A MXPA03004288A MX PA03004288 A MXPA03004288 A MX PA03004288A MX PA03004288 A MXPA03004288 A MX PA03004288A MX PA03004288 A MXPA03004288 A MX PA03004288A MX PA03004288 A MXPA03004288 A MX PA03004288A
Authority
MX
Mexico
Prior art keywords
apomorphine
treatment
sexual dysfunction
induced sexual
depression drug
Prior art date
Application number
MXPA03004288A
Other languages
English (en)
Inventor
Renee J Perdok
Original Assignee
Tap Pharmaceutical Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tap Pharmaceutical Prod Inc filed Critical Tap Pharmaceutical Prod Inc
Publication of MXPA03004288A publication Critical patent/MXPA03004288A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describe un metodo para tratar la disfuncion sexual en un paciente que toma medicamento antidepresivo en necesidad de tal tratamiento comprendiendo administrar una cantidad terapeuticamente eficaz de apomorfina o una sal farmaceuticamente aceptable de la misma a dicho paciente. El metodo puede utilizarse por pacientes que toman antidepresivos tales como antidepresivos triciclicos, inhibidores de oxidasa de monamina o inhibidores de reabsorcion selectiva de serotonina.
MXPA03004288A 2000-11-15 2001-11-14 Tratamiento de disfuncion sexual inducida por farmaco antidepresivo con apomorfina. MXPA03004288A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24903100P 2000-11-15 2000-11-15
PCT/US2001/043933 WO2002039879A2 (en) 2000-11-15 2001-11-14 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine

Publications (1)

Publication Number Publication Date
MXPA03004288A true MXPA03004288A (es) 2004-09-10

Family

ID=22941748

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03004288A MXPA03004288A (es) 2000-11-15 2001-11-14 Tratamiento de disfuncion sexual inducida por farmaco antidepresivo con apomorfina.

Country Status (18)

Country Link
US (1) US6528521B2 (es)
EP (1) EP1341536A4 (es)
JP (1) JP2004513899A (es)
KR (1) KR20030077538A (es)
CN (1) CN1486183A (es)
AU (1) AU2002235129A1 (es)
BG (1) BG107874A (es)
BR (1) BR0111982A (es)
CA (1) CA2429047A1 (es)
CZ (1) CZ20031540A3 (es)
HU (1) HUP0302436A3 (es)
IL (1) IL155667A0 (es)
MX (1) MXPA03004288A (es)
NO (1) NO20032189L (es)
PL (1) PL361875A1 (es)
SK (1) SK7422003A3 (es)
WO (1) WO2002039879A2 (es)
ZA (1) ZA200303471B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US20040204439A1 (en) * 2003-04-14 2004-10-14 Staniforth John Nicholas Composition, device, and method for treating sexual dysfunction via inhalation
AU2004228757A1 (en) * 2003-04-14 2004-10-21 Vectura Ltd Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
EP1667972B1 (en) 2003-09-10 2013-06-19 Brentwood Equities Ltd. Diastereomers of 4-aryloxy-3-hydroxypiperidines
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0721394D0 (en) * 2007-10-31 2007-12-12 Vectura Group Plc Compositions for trating parkinson's disease
EA031156B1 (ru) 2010-12-16 2018-11-30 Суновион Фармасьютикалз Инк. Сублингвальные пленки
CA3178035A1 (en) 2012-12-24 2014-07-03 Neurogastrx, Inc. Methods for treating gi tract disorders
CA3019769C (en) 2015-04-21 2021-10-12 Sunovion Pharmaceuticals Inc. Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
CA3088824A1 (en) * 2018-01-18 2019-07-25 Leukos Biotech, S. L. Apomorphine·palmitic acid cocrystal solid particle crystalline form
US11717495B2 (en) * 2020-03-16 2023-08-08 Vella Bioscience, Inc. Use of cannabinoids in treating anti-depressant-induced female sexual dysfunction
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine
CN115671106B (zh) * 2021-07-21 2024-03-19 广州新济药业科技有限公司 吗啡的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
EP0865789B1 (en) * 1993-03-26 2005-03-16 Franciscus Wilhelmus Henricus Maria Merkus Pharmaceutical compositions for intranasal administration of dihydroergotamine
DE10199068I2 (de) 1994-04-22 2004-05-06 Pentech Pharmaceuticals Inc Sublinguale Dosierungsformen enthaltend apomorphinzur Verwendung bei der Behandlung von erektiler D ysfunktion.
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
US5888534A (en) * 1995-06-13 1999-03-30 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
DE69709646T2 (de) 1996-03-12 2002-08-14 Alza Corp Zusammensetzung und dosisform mit einem opioid-antagonisten
US5897864A (en) 1996-05-23 1999-04-27 Cohen; Alan J. Method for treating sexual dysfunction disorders with compositions containing ginkgo biloba
WO1998024442A1 (en) * 1996-12-02 1998-06-11 Merck Sharp & Dohme Limited Use of nk-1 receptor antagonists for treating sexual dysfunction
US5945117A (en) 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
US6399826B1 (en) * 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain

Also Published As

Publication number Publication date
CA2429047A1 (en) 2002-05-23
US6528521B2 (en) 2003-03-04
HUP0302436A2 (hu) 2003-11-28
IL155667A0 (en) 2003-11-23
HUP0302436A3 (en) 2004-10-28
AU2002235129A1 (en) 2002-05-27
NO20032189L (no) 2003-07-08
EP1341536A4 (en) 2007-08-01
EP1341536A2 (en) 2003-09-10
ZA200303471B (en) 2004-08-06
CN1486183A (zh) 2004-03-31
PL361875A1 (en) 2004-10-04
BG107874A (bg) 2004-01-30
WO2002039879A2 (en) 2002-05-23
CZ20031540A3 (cs) 2004-05-12
US20020115683A1 (en) 2002-08-22
KR20030077538A (ko) 2003-10-01
SK7422003A3 (en) 2004-01-08
BR0111982A (pt) 2003-10-28
WO2002039879A3 (en) 2002-07-25
JP2004513899A (ja) 2004-05-13
NO20032189D0 (no) 2003-05-14

Similar Documents

Publication Publication Date Title
BE2012C040I2 (es)
MXPA03004288A (es) Tratamiento de disfuncion sexual inducida por farmaco antidepresivo con apomorfina.
HK1051684A1 (en) Azacyclic compounds for use in the treatment of serotonin related diseases
EA200501496A1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
KR980000447A (ko) 미르타자핀과 하나 이상의 선택적인 세로토닌 재이용 저해제로 이루어진 약학 조성물
BR0316753A (pt) Método de tratamento para disfunção sexual
EA200802412A1 (ru) Терапевтические комбинации для сопровождающихся болью медицинских состояний
CA2632207C (en) Use of calcitonin for the treatment of ra
TW200607802A (en) 3-piperidinylisochroman-5-ols as dopamine agonists
WO2004105690A3 (en) Treatment of chronic pain associated with drug or radiation therapy
GB0405381D0 (en) A method and means for treating heart failure
WO2005055933A3 (en) Treatment of psoriasis with rosiglitazone
EA200802159A1 (ru) Введение агониста-антагониста пациентам с опиоидной зависимостью
TW200505427A (en) A solid oral dosage form of metformin and glyburide and the method of preparation thereof
MXPA06002778A (es) Combinacion de inhibidores de recaptacion de serotonina e inhibidores de recaptacion de norepinefrina.
WO2008060381A3 (en) Method for treating pain or opioid dependence using a specific type of non-opioid agent in combination with a selective excitatory-opioid-receptor inactivator
MD2375F1 (en) Method of portal gastropathy treatment in hepatic cirrhosis
UY27037A1 (es) Composición de apomorfina para tratar la disfunción sexual con niveles específicos de concentración en plasma
AR037315A1 (es) Uso de la apomorfina en la fabricacion de un medicamento util para la disfuncion sexual inducida por drogas antidepresivas